Status:
COMPLETED
Efficacy of Oral Vitamin D Supplementation in Adolescents and Young Adults.
Lead Sponsor:
Fundación Cardiovascular de Colombia
Collaborating Sponsors:
Universidad Industrial de Santander
Farma de Colombia SA
Conditions:
Overweight and Obesity
Overweight Adolescents
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study assesses whether oral supplementation with vitamin D contributes to the reduction of body mass index and lipid profile in adolescents and young adults. The intervention group will receive 1...
Detailed Description
Sample size: the simple size was calculated considering the following parameters: an expected difference in the study outcomes (overweight, obesity, and alteration of the lipid profile) of 20% between...
Eligibility Criteria
Inclusion
- Belonging to the SIMBA cohort.
- Age ≥ 18 years.
- Re-contact consent from previous studies.
Exclusion
- Medical diagnosis of diabetes mellitus, clinically manifest endocrinopathies, acute or chronic infectious liver disease, and kidney disease.
- Adolescents or Young adults subject to treatment with steroids or hormones (except levothyroxine) up to one month before lab sample taking.
- Current supplementation with VD (any form).
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04377386
Start Date
August 3 2020
End Date
February 2 2021
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Cardiovascular de Colombia
Floridablanca, Santander Department, Colombia, 681004